Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors

JOURNAL ARTICLE published 31 July 2022 in Cancers

Research funded by Beijing Natural Science Foundation (Z210015) | Clinical Medicine Plus X - Young Scholars Project of Peking University (PKU2019LCXQ020,PKU2018LCXQ018,BMU2022PYB026)

Authors: Zhening Zhang | Tong Xie | Changsong Qi | Xiaotian Zhang | Lin Shen | Zhi Peng